Skip to content

Platform Therapeutic Education in Heart Failure and Coronary Disease

Telephonic Platform of Follow up, Therapeutical Education and Coordination in Secondary Prevention in Patients With Heart Failure and Coronary Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01869452
Acronym
METISCARDIO
Enrollment
555
Registered
2013-06-05
Start date
2010-05-31
Completion date
2014-06-30
Last updated
2015-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Coronary Bypass Graft Stenosis of Native Artery Graft, Heart Failure

Keywords

education, risk factors, quality of life, coronary disease, telephone follow up, dedicated nurse

Brief summary

A first therapeutic education is given before patient's discharge at the hospital, then a dedicated nurse follows patients through the phone,regularly according to patients' needs, continues to give advise on risk factors, information on medication and alert symptoms and therapeutic education.

Detailed description

Patients are assigned to an arm accordingly to their needs: class 1 with light therapeutic education, class 2 with moderate education, class 3 with heavy education. Assignement is based on the first education diagnosis during hospitalization time. Quality of life and patient's knowledge are regularly evaluated through questionnaires

Interventions

BEHAVIORALtherapeutic education

knowledge of disease, risk factors, diet, medication, alert symptoms

Sponsors

union nationale de formation et d'evaluation en medecine cardio-vasculaire
CollaboratorUNKNOWN
Resicard
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* hospitalization for acute coronary syndrome (ST-segment elevation myocardial infarction ,no ST-segment elevation myocardial infarction ST , unstable angina) * hospitalization for heart failure * acute coronary syndrome \< 3 months * heart failure \< 3 months * coronary by-pass surgery \< 3 months

Exclusion criteria

* complicated acute coronary syndrome (ventricular arrhythmia, heart failure, mechanical complications, cardiogenic shock) * valvular cardiac pathology * obstructive cardiomyopathy * planned cardiac transplantation * severe neurological or psychiatric troubles * loss of autonomy * other (refusal, language, nursing house, way of life not compatible with follow up, refusal of telephonic contacts)

Design outcomes

Primary

MeasureTime frameDescription
number of patient with a better of quality of life1 yearquality of life is evaluated with appropriate questionnaires

Secondary

MeasureTime frameDescription
number of patients who improve their knowledge of disease1 yearKnowledge of disease includes risk factors, symptoms, medication, diet. It is evaluated with appropriate questionnaires.
number of hospitalizations during the follow up1 yearhospitalizations are recorded during the year of follow up, with cause and duration.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026